AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,004,207 | -8.0% | 57,293 | -5.4% | 0.00% | 0.0% |
| Q2 2023 | $4,352,776 | +75.4% | 60,573 | +50.6% | 0.00% | +33.3% |
| Q1 2023 | $2,480,954 | -28.7% | 40,223 | -10.9% | 0.00% | -25.0% |
| Q4 2022 | $3,481,803 | +26.7% | 45,142 | -26.7% | 0.00% | +33.3% |
| Q3 2022 | $2,749,000 | +98.3% | 61,616 | +70.2% | 0.00% | +200.0% |
| Q2 2022 | $1,386,000 | -27.5% | 36,203 | -21.6% | 0.00% | -50.0% |
| Q1 2022 | $1,911,000 | -58.6% | 46,159 | -62.2% | 0.00% | 0.0% |
| Q4 2021 | $4,619,000 | +42.2% | 122,243 | +24.0% | 0.00% | 0.0% |
| Q3 2021 | $3,249,000 | +37.1% | 98,582 | +180.6% | 0.00% | +100.0% |
| Q2 2021 | $2,369,000 | +7.7% | 35,127 | -9.5% | 0.00% | 0.0% |
| Q1 2021 | $2,199,000 | -25.8% | 38,833 | +6.8% | 0.00% | 0.0% |
| Q4 2020 | $2,963,000 | +85.2% | 36,370 | +62.0% | 0.00% | 0.0% |
| Q3 2020 | $1,600,000 | -28.4% | 22,452 | -17.3% | 0.00% | -50.0% |
| Q2 2020 | $2,234,000 | +140.7% | 27,148 | +72.0% | 0.00% | +100.0% |
| Q1 2020 | $928,000 | -77.9% | 15,780 | -61.1% | 0.00% | -66.7% |
| Q4 2019 | $4,193,000 | +1030.2% | 40,567 | +121.4% | 0.00% | – |
| Q3 2019 | $371,000 | -35.3% | 18,322 | -17.7% | 0.00% | -100.0% |
| Q2 2019 | $573,000 | +516.1% | 22,265 | +31.3% | 0.00% | – |
| Q2 2017 | $93,000 | – | 16,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |